Antitumor Activity of Probiotic Bacteria and the Bacterial Association in the Tumor Growth Model and in Cell Culture


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

Strains of lactic acid and propionic acid bacteria and the A-5 bacterial association composed of the Lactobacillus brevis B-3/A-26, L. plantarum 2v/А-6, L. plantarum 14d/I, and Propionibacterium shermanii 2/10 cultures in equal proportion exhibiting high antitumor activity have been selected using the fungus Fusarium bulbigenum var. blasticola tumorlike growth model. L. acidophilus 27w, L. plantarum 2v/I, 2v/A-6, and 22A-310, L. fermentum 127A-4, L. cellobiosus 7n, L. salivarius 39n, P. shermanii 2/10, and the А-5 association were shown to inhibit completely the tumorlike growth of the fungus when present as 2% native cultures in the nutrient medium. The high antitumor activity of the A-5 association comparable with that of the therapeutic agents doxorubicin and cyclophosphamide was confirmed using human tumor cell lines originating from different organs (HepG2, RD, and H9). It has been demonstrated that the bacterial strains comprising the A-5 association were resistant to doxorubicin and methotrexate, the antitumor drugs tested.

Авторлар туралы

I. Ratnikova

Institute of Microbiology and Virology

Хат алмасуға жауапты Автор.
Email: iratnikova@list.ru
Қазақстан, Almaty, 050000

N. Gavrilova

Institute of Microbiology and Virology

Email: iratnikova@list.ru
Қазақстан, Almaty, 050000

K. Bayakyshova

Institute of Microbiology and Virology

Email: iratnikova@list.ru
Қазақстан, Almaty, 050000

Z. Turlybaeva

Institute of Microbiology and Virology

Email: iratnikova@list.ru
Қазақстан, Almaty, 050000

L. Kosheleva

Institute of Microbiology and Virology

Email: iratnikova@list.ru
Қазақстан, Almaty, 050000

N. Utegenova

Institute of Microbiology and Virology

Email: iratnikova@list.ru
Қазақстан, Almaty, 050000

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Pleiades Publishing, Inc., 2018